18818487. SOLID FORMS OF FXR AGONISTS (Gilead Sciences, Inc.)
SOLID FORMS OF FXR AGONISTS
Organization Name
Inventor(s)
Derek M. Dalton of Berkeley CA US
Peter C. Fung of San Mateo CA US
Nolan Griggs of San Mateo CA US
Jeffrey N. Hemenway of San Mateo CA US
Olga V. Lapina of Newark CA US
Matthew M. Logan of San Mateo CA US
Sean T. Neville of San Mateo CA US
Bryan J. Reynolds of Chicago IL US
Hui-Wen Shih of San Mateo CA US
Anna M. Wagner of San Francisco CA US
SOLID FORMS OF FXR AGONISTS
This abstract first appeared for US patent application 18818487 titled 'SOLID FORMS OF FXR AGONISTS
Original Abstract Submitted
Disclosed herein are novel solid forms of FXR agonists. The disclosure also relates to pharmaceutical compositions containing one or more of the solid forms disclosed herein, as well as methods of using the solid forms in the treatment of conditions mediated by FXR. The disclosure also relates to methods for obtaining such solid forms.
- Gilead Sciences, Inc.
- Derek M. Dalton of Berkeley CA US
- Peter C. Fung of San Mateo CA US
- Nolan Griggs of San Mateo CA US
- Jeffrey N. Hemenway of San Mateo CA US
- Olga V. Lapina of Newark CA US
- Matthew M. Logan of San Mateo CA US
- Sean T. Neville of San Mateo CA US
- Bryan J. Reynolds of Chicago IL US
- Hui-Wen Shih of San Mateo CA US
- Anna M. Wagner of San Francisco CA US
- A61K31/4439
- C07D401/14
- C07D413/14
- CPC A61K31/4439